Evaluation of Full Versus Fractional Doses of COVID-19 Vaccines Given as a Booster in Adults in Australia - Mongolia, Indonesia, Australia Coronavirus (MIACoV).
Condition: COVID-19 Interventions: Biological: Tozinameran - Standard dose; Biological: Tozinameran - fractional dose; Biological: Elasomeran - standard dose; Biological: Elasomeran - fractional dose Sponsors: Murdoch Childrens Research Institute; Coalition for Epidemic Preparedness Innovations; PATH; The Peter Doherty Institute for Infection and Immunity Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2022 Category: Research Source Type: clinical trials
SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial
Condition: Stroke, Acute Interventions: Drug: SPT-07A injection; Other: placebo Sponsors: Wuhan Union Hospital, China; Suzhou Huyun New Drug Research and Development Co., Ltd; Shanghai Canming Pharmaceutical Technology Co., Ltd; Beijing Haijinge Pharmaceutical Technology Co., Ltd; The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Sci ence and Technology; Xiang Yang NO.1 People's Hospital; Xiangyang Central Hospital; Wuhan NO. 4 hospital; The Affiliated Hospital of Xuzhou Medical University; Xuzhou Central Hospital; Yan'an Unive...
Source: ClinicalTrials.gov - December 16, 2021 Category: Research Source Type: clinical trials
